| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.07 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.08 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.32 | 0.08 |